Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials01:16

Clinical Trials

7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.5K
Study Design in Statistics01:15

Study Design in Statistics

8.4K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.4K
Crossover Experiments01:16

Crossover Experiments

3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Effects of Long-Term Fertilization Regimes on Crop Yield Stability and Grain Quality in Maize and Winter Wheat Rotation of Northern China.

Plants (Basel, Switzerland)·2026
Same author

Impacts of climate change on greenhouse gas emissions from wastewater: a critical review.

Bioresource technology·2026
Same author

Acute cerebral infarction caused by severe anaphylactic shock: A case report.

Journal of anesthesia and translational medicine·2026
Same author

Border-Associated Macrophages in CNS Health and Disease: A Comprehensive Review of Ontogeny, Heterogeneity, and Functional Plasticity at Neural Interfaces.

ASN neuro·2026
Same author

Baicalein activates the type I interferon signaling pathway to inhibit infectious bronchitis virus infection.

Poultry science·2026
Same author

Stabilizing O3-type layered oxide cathodes <i>via</i> dual-site co-doping for long-life sodium-ion batteries.

Chemical science·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Un diseño robusto de optimización de dosis bayesiana con relleno y aleatorización para ensayos clínicos de fase I/II

Yingjie Qiu1,2, Mingyue Li1

  • 1Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Statistical methods in medical research
|September 5, 2025
PubMed
Resumen

Las cohortes de relleno en ensayos de fase I mejoran la seguridad y la eficiencia de los nuevos medicamentos contra el cáncer. Este diseño bayesiano mejora la selección de dosis óptima y reduce la exposición del paciente a tratamientos ineficaces.

Palabras clave:
El rellenodiseños adaptativosOptimización de la dosisproyecto optimusCompromiso entre el riesgo y los beneficios

Más Videos Relacionados

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Área de la Ciencia:

  • Farmacología clínica
  • Estadísticas biológicas
  • Desarrollo de fármacos en oncología

Sus antecedentes:

  • Los ensayos clínicos de fase I son cruciales para evaluar nuevas terapias contra el cáncer, incluidas las terapias dirigidas y las inmunoterapias.
  • La guía del Proyecto Optimus de la Administración de Alimentos y Medicamentos de los Estados Unidos (agosto de 2024) destaca la importancia de la optimización de la dosis.
  • Los diseños de ensayos tradicionales pueden no reflejar adecuadamente las complejidades de la relación dosis-respuesta de los nuevos agentes, en los que la eficacia puede no estar correlacionada con la dosis.

Objetivo del estudio:

  • Introducir un marco de diseño bayesiano para la integración de cohortes de relleno en ensayos clínicos de fase I.
  • Mejorar la evaluación de la seguridad y eficacia de los nuevos tratamientos contra el cáncer.
  • Optimizar la selección de la dosis mientras se minimiza el riesgo para el paciente y la duración del ensayo.

Principales métodos:

  • Desarrollo de un marco de diseño bayesiano robusto para estudios de determinación de dosis.
  • Tomar prestada información a través de niveles de dosis sin suposiciones parámetricas estrictas sobre las relaciones dosis-respuesta.
  • Evaluación conjunta de la toxicidad y la eficacia, abordando los retos de los resultados retrasados.

Principales resultados:

  • El diseño propuesto genera datos valiosos para estudios posteriores.
  • Mejor precisión en la selección de la dosis óptima para nuevas terapias contra el cáncer.
  • Mejora de la seguridad del paciente mediante la reducción de la administración de dosis subterapéuticas.

Conclusiones:

  • El diseño de relleno bayesiano ofrece un enfoque superior para los ensayos de fase I de nuevos medicamentos contra el cáncer.
  • Este marco equilibra efectivamente la exploración de la dosis con la seguridad del paciente y la eficiencia del ensayo.
  • Los estudios de simulación confirman las ventajas del diseño en varios entornos de ensayo clínico realistas.